Rowlandmiller & PARTNERS.ADV reduced its stake in Aflac Incorporated (NYSE:AFL – Free Report) by 6.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 29,297 shares of the financial services provider’s stock after selling 2,076 shares during the period. Rowlandmiller & PARTNERS.ADV’s holdings in Aflac were worth $3,031,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Darwin Wealth Management LLC bought a new position in Aflac during the third quarter worth about $34,000. Raelipskie Partnership bought a new position in Aflac during the third quarter worth about $38,000. Covestor Ltd lifted its holdings in Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after acquiring an additional 107 shares in the last quarter. Kennebec Savings Bank bought a new position in Aflac during the third quarter worth about $45,000. Finally, Catalyst Capital Advisors LLC bought a new position in Aflac during the third quarter worth about $51,000. 67.44% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several research analysts have weighed in on the company. Wells Fargo & Company reduced their target price on Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 19th. JPMorgan Chase & Co. lifted their target price on Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a report on Tuesday, January 7th. Barclays cut their price target on Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a report on Friday, February 7th. Keefe, Bruyette & Woods cut their price target on Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a report on Wednesday, February 12th. Finally, Truist Financial boosted their price target on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a report on Friday, November 1st. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Aflac has a consensus rating of “Hold” and an average price target of $102.86.
Aflac Price Performance
NYSE:AFL opened at $102.04 on Monday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The stock’s 50-day simple moving average is $104.11 and its 200 day simple moving average is $107.41. The company has a market cap of $56.69 billion, a P/E ratio of 10.63, a P/E/G ratio of 3.31 and a beta of 0.99. Aflac Incorporated has a 52-week low of $78.62 and a 52-week high of $115.50.
Aflac (NYSE:AFL – Get Free Report) last released its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, sell-side analysts forecast that Aflac Incorporated will post 6.88 EPS for the current fiscal year.
Aflac Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be given a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a yield of 2.27%. The ex-dividend date of this dividend is Wednesday, February 19th. This is an increase from Aflac’s previous quarterly dividend of $0.50. Aflac’s payout ratio is 24.17%.
Insiders Place Their Bets
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the transaction, the executive vice president now owns 222,618 shares of the company’s stock, valued at $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.90% of the company’s stock.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Stories
- Five stocks we like better than Aflac
- What is Forex and How Does it Work?
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Bank Stocks – Best Bank Stocks to Invest In
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Best Aerospace Stocks Investing
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.